Pathological Complete Response to Nivolumab, S1, Oxaliplatin, and Radiation in a Patient with Gastric Cancer: a Case Report

被引：0
|
作者：
Kazuhiro Toyota
Yasushi Hashimoto
Yoshihiro Sakashita
Yujiro Yokoyama
Yoshiaki Murakami
Shinya Takahashi
Katsunari Miyamoto
机构：
[1] Hiroshima Memorial Hospital,Department of Surgery
[2] Hiroshima University,Department of Surgery, Graduate School of Biomedical and Health Sciences
来源：
Journal of Gastrointestinal Cancer | 2023年 / 54卷
关键词：
Gastric cancer; Nivolumab; S1 plus oxaliplatin; Radiation; Complete response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1000 / 1002
页数：2
相关论文
共 50 条
  • [1] Pathological Complete Response to Nivolumab, S1, Oxaliplatin, and Radiation in a Patient with Gastric Cancer: a Case Report
    Toyota, Kazuhiro
    Hashimoto, Yasushi
    Sakashita, Yoshihiro
    Yokoyama, Yujiro
    Murakami, Yoshiaki
    Takahashi, Shinya
    Miyamoto, Katsunari
    JOURNAL OF GASTROINTESTINAL CANCER, 2023, 54 (03) : 1000 - 1002
  • [2] Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report
    Ryu Matsumoto
    Takaaki Arigami
    Daisuke Matsushita
    Keishi Okubo
    Takako Tanaka
    Shigehiro Yanagita
    Ken Sasaki
    Masahiro Noda
    Yoshiaki Kita
    Shinichiro Mori
    Hiroshi Kurahara
    Takao Ohtsuka
    World Journal of Surgical Oncology, 18
  • [3] Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report
    Matsumoto, Ryu
    Arigami, Takaaki
    Matsushita, Daisuke
    Okubo, Keishi
    Tanaka, Takako
    Yanagita, Shigehiro
    Sasaki, Ken
    Noda, Masahiro
    Kita, Yoshiaki
    Mori, Shinichiro
    Kurahara, Hiroshi
    Ohtsuka, Takao
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)
  • [4] Case report: pathological complete response after S-1/oxaliplatin regimen combined with trastuzumab and tislelizumab in patients with locally advanced gastric cancer
    Zhu, Chenglou
    Da, Mingxu
    Li, Yaoqi
    Peng, Lingzhi
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [5] Complete Pathological Response in a Patient with Metastatic Esophageal Cancer Treated with a Regimen of Capecitabine, Oxaliplatin and Docetaxel: A Case Report
    Seetharamu N.
    Melamed J.
    Miller G.
    Rotterdam H.
    Gonda T.
    Villanueva G.
    Halmos B.
    Journal of Gastrointestinal Cancer, 2014, 45 (Suppl 1) : 108 - 111
  • [6] Successful treatment of gastric cancer after complete response of lung cancer by nivolumab: a case report
    Shunji Endo
    Yoshinori Fujiwara
    Koji Kurose
    Masaharu Higashida
    Hisako Kubota
    Yuko Okamoto
    Shumei Mineta
    Hironori Tanaka
    Toshimasa Okada
    Atsushi Tsuruta
    Takashi Akiyama
    Toru Oga
    Tomio Ueno
    Surgical Case Reports, 6
  • [7] Successful treatment of gastric cancer after complete response of lung cancer by nivolumab: a case report
    Endo, Shunji
    Fujiwara, Yoshinori
    Kurose, Koji
    Higashida, Masaharu
    Kubota, Hisako
    Okamoto, Yuko
    Mineta, Shumei
    Tanaka, Hironori
    Okada, Toshimasa
    Tsuruta, Atsushi
    Akiyama, Takashi
    Oga, Toru
    Ueno, Tomio
    SURGICAL CASE REPORTS, 2020, 6 (01)
  • [8] Confirmed complete response to nivolumab for advanced gastric cancer with peritoneal dissemination: a case report
    Tomoya Takami
    Koji Yasuda
    Nozomi Uozumi
    Yutaka Musiake
    Hiroshi Shintani
    Naoki Kataoka
    Tomoyuki Yamaguchi
    Shinichiro Makimoto
    Journal of Medical Case Reports, 15
  • [9] Confirmed complete response to nivolumab for advanced gastric cancer with peritoneal dissemination: a case report
    Takami, Tomoya
    Yasuda, Koji
    Uozumi, Nozomi
    Musiake, Yutaka
    Shintani, Hiroshi
    Kataoka, Naoki
    Yamaguchi, Tomoyuki
    Makimoto, Shinichiro
    JOURNAL OF MEDICAL CASE REPORTS, 2021, 15 (01)
  • [10] A pathological complete response to capecitabine plus oxaliplatin regimen combined with tislelizumab in advanced gastric cancer with liver metastases: A case report
    Sheng, Li-Ping
    Huang, Yun-Lin
    Wang, Zhi
    Zhang, Hai-Fang
    Zhang, Jin-Yan
    Lei, Xiao-Yi
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
12345